vimarsana.com
Home
Live Updates
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering : vimarsana.com
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
Boca Raton, Florida - INmune Bio, Inc. , a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced today...
Related Keywords
New York ,
United States ,
Florida ,
Boca Raton ,
Jason Nelson ,
David Moss ,
Inmune Bio ,
Company Quarterly Reports On Form ,
Lifesci Capital ,
Company Annual Report On Form ,
Drug Administration ,
Company Phase ,
Nasdaq ,
Company Current Reports On Form ,
Inmune Bio Inc ,
Exchange Commission ,
Termination Date ,
Early Alzheimer ,
Sci Capital ,
Dominant Negative Tumor Necrosis Factor ,
Natural Killer Cell Priming Platform ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
News Publishing ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.